OmniAb (OABI) Equity Average (2021 - 2026)
OmniAb (OABI) reported Equity Average of $264.8 million for Q1 2026, down 5.61% year-over-year from $280.6 million in Q1 2025, and down 2.72% quarter-over-quarter from $272.2 million in Q4 2025.
OmniAb (OABI) Equity Average (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Equity Average data on file, last reported at $264.8 million in Q1 2026.
- Equity Average for Q1 2026 came in at $264.8 million, down 5.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $264.8 million (down 5.61% YoY), and the FY2025 annual result was $277.3 million, down 7.9% from the prior year.
- Equity Average slipped to $264.8 million in Q1 2026 per OABI's latest filing, from $272.2 million in the prior quarter.
- Over five years, Equity Average peaked at $341.1 million in Q1 2023 and troughed at $225.9 million in Q2 2022.
- A 5-year average of $284.9 million and a median of $287.0 million in 2022 frame the typical range for Equity Average.
- The sharpest annual moves came in 2022 and 2024: Equity Average surged 1401332.87% in 2022, then retreated 11.72% in 2024.
- A 5-year view of Equity Average shows it stood at $287.0 million in 2022, then climbed by 11.33% to $319.6 million in 2023, then slipped by 9.35% to $289.7 million in 2024, then retreated by 6.02% to $272.2 million in 2025, then dropped by 2.72% to $264.8 million in 2026.
- Business Quant data shows OABI's Equity Average at $264.8 million in Q1 2026, $272.2 million in Q4 2025, and $269.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 264.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 264.84 Mn |
| Dec 31, 2025 | 272.24 Mn |
| Sep 30, 2025 | 269.75 Mn |
| Jun 30, 2025 | 267.79 Mn |
| Mar 31, 2025 | 280.57 Mn |
| Dec 31, 2024 | 289.67 Mn |
| Sep 30, 2024 | 292.95 Mn |
| Jun 30, 2024 | 297.79 Mn |
| Mar 31, 2024 | 307.99 Mn |
| Dec 31, 2023 | 319.57 Mn |
| Sep 30, 2023 | 329.18 Mn |
| Jun 30, 2023 | 337.30 Mn |
| Mar 31, 2023 | 341.09 Mn |
| Dec 31, 2022 | 287.04 Mn |
| Sep 30, 2022 | 229.83 Mn |
| Jun 30, 2022 | 225.93 Mn |
| Mar 31, 2022 | 229.61 Mn |
| Dec 31, 2021 | 113.70 Mn |
| Sep 30, 2021 | -3.44 Mn |
| Jun 30, 2021 | 16,121.50 |